Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease
出版年份 2017 全文链接
标题
Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease
作者
关键词
-
出版物
MOVEMENT DISORDERS
Volume 32, Issue 6, Pages 893-903
出版商
Wiley
发表日期
2017-03-31
DOI
10.1002/mds.26976
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study)
- (2015) Rajesh Pahwa et al. MOVEMENT DISORDERS
- What is a clinically important change in the Unified Dyskinesia Rating Scale in Parkinson's disease?
- (2015) Tiago A. Mestre et al. PARKINSONISM & RELATED DISORDERS
- Dextromethorphan/Quinidine for Chorea
- (2012) William G. Ondo CLINICAL NEUROPHARMACOLOGY
- Anti-dyskinetic mechanisms of amantadine and dextromethorphan in the 6-OHDA rat model of Parkinson’s disease: role of NMDA vs. 5-HT1A receptors
- (2012) Melanie A. Paquette et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults
- (2011) Kelly Posner et al. AMERICAN JOURNAL OF PSYCHIATRY
- Glutamate NMDA receptor dysregulation in Parkinson’s disease with dyskinesias
- (2011) Imtiaz Ahmed et al. BRAIN
- Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation
- (2011) Mahmoud M. Iravani et al. JOURNAL OF NEURAL TRANSMISSION
- Amantadine for Dyskinesias in Parkinson's Disease: A Randomized Controlled Trial
- (2011) Hideyuki Sawada et al. PLoS One
- Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap
- (2010) Paolo Calabresi et al. LANCET NEUROLOGY
- Long-term antidyskinetic efficacy of amantadine in Parkinson's disease
- (2010) Elisabeth Wolf et al. MOVEMENT DISORDERS
- Systematic review of levodopa dose equivalency reporting in Parkinson's disease
- (2010) Claire L. Tomlinson et al. MOVEMENT DISORDERS
- Pharmacology and Therapeutic Potential of Sigma1 Receptor Ligands
- (2009) E. Cobos et al. Current Neuropharmacology
- Serotonin and Parkinson's disease: On movement, mood, and madness
- (2009) Susan H. Fox et al. MOVEMENT DISORDERS
- The pharmacology of sigma-1 receptors
- (2009) Tangui Maurice et al. PHARMACOLOGY & THERAPEUTICS
- Levodopa-induced dyskinesia and striatal signaling pathways
- (2009) A. Pisani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism
- (2009) Melanie A. Paquette et al. PSYCHOPHARMACOLOGY
- The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Molecular mechanisms of L-DOPA-induced dyskinesia
- (2008) Peter Jenner NATURE REVIEWS NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More